The Covid-19 pandemic has ushered in a new era in medicine – that of mRNA technology. But the potential of mRNA for preventing and treating a whole range of diseases goes beyond Covid-19. This industry forum addresses some key considerations for mRNA technology and what these might mean for the future.
Biotech pioneer and professor of biochemistry Pieter Cullis will open this forum with a talk about the beginnings of lipid nanoparticles in the early 1990s, and how they rose to become the industry’s standard technology for the delivery of mRNA and other nucleic acid-based drugs.
Undisputedly, mRNA technology has a promising future. Will there soon be an mRNA vaccine for malaria or cancer? Our second speaker, Ulrich Blaschke of BioNTech, will discuss the potential future applications of mRNA technologies and shed light on what could be the next breakthrough.
The industry forum is hosted by Evonik Health Care, represented through Maaike Everts and Stefan Randl. As one of the few integrated system solutions providers for the pharma and biotech industries, Evonik’s Maaike Everts and Stefan Randl will take the audience through advanced mixing and formulation technologies for mRNA and other nucleic acids therapeutics.
Participants will have the opportunity to ask questions to the speakers during the session!